IL-2 is a noted anti-tumor factor, low dose of which presented the ability of enhancing the antibody-dependent cellular cytotoxicity (ADCC) effect (125–128), as well as the cytotoxic effect mediated by immuno-conjugate molecule (hI-con1) (129) to USPC cells. Here, IL2 is linked to neoplasm.